IL93744A - Medicinal preparations containing quinolinones and ECA inhibitors - Google Patents
Medicinal preparations containing quinolinones and ECA inhibitorsInfo
- Publication number
- IL93744A IL93744A IL9374490A IL9374490A IL93744A IL 93744 A IL93744 A IL 93744A IL 9374490 A IL9374490 A IL 9374490A IL 9374490 A IL9374490 A IL 9374490A IL 93744 A IL93744 A IL 93744A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- formula
- ace
- methyl
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32421389A | 1989-03-15 | 1989-03-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL93744A0 IL93744A0 (en) | 1990-12-23 |
| IL93744A true IL93744A (en) | 1995-06-29 |
Family
ID=23262607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL9374490A IL93744A (en) | 1989-03-15 | 1990-03-14 | Medicinal preparations containing quinolinones and ECA inhibitors |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0527720B1 (es) |
| JP (1) | JPH04503806A (es) |
| KR (1) | KR920700642A (es) |
| AT (1) | ATE109981T1 (es) |
| AU (1) | AU640128B2 (es) |
| CA (1) | CA2049980A1 (es) |
| DE (1) | DE69011692T2 (es) |
| DK (1) | DK0527720T3 (es) |
| ES (1) | ES2057542T3 (es) |
| IE (1) | IE65902B1 (es) |
| IL (1) | IL93744A (es) |
| WO (1) | WO1990010445A1 (es) |
| ZA (1) | ZA901945B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0651640A1 (en) * | 1992-07-21 | 1995-05-10 | Knoll AG | Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3542794A1 (de) * | 1985-12-04 | 1987-06-11 | Bayer Ag | Antihypertensives kombinationspraeparat |
-
1990
- 1990-03-07 IE IE81890A patent/IE65902B1/en not_active IP Right Cessation
- 1990-03-12 AT AT90904349T patent/ATE109981T1/de not_active IP Right Cessation
- 1990-03-12 WO PCT/EP1990/000430 patent/WO1990010445A1/en active IP Right Grant
- 1990-03-12 EP EP90904349A patent/EP0527720B1/en not_active Expired - Lifetime
- 1990-03-12 CA CA002049980A patent/CA2049980A1/en not_active Abandoned
- 1990-03-12 JP JP2504547A patent/JPH04503806A/ja active Pending
- 1990-03-12 AU AU52616/90A patent/AU640128B2/en not_active Ceased
- 1990-03-12 DE DE69011692T patent/DE69011692T2/de not_active Expired - Fee Related
- 1990-03-12 ES ES90904349T patent/ES2057542T3/es not_active Expired - Lifetime
- 1990-03-12 KR KR1019910701111A patent/KR920700642A/ko not_active Application Discontinuation
- 1990-03-12 DK DK90904349.9T patent/DK0527720T3/da active
- 1990-03-14 ZA ZA901945A patent/ZA901945B/xx unknown
- 1990-03-14 IL IL9374490A patent/IL93744A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1990010445A1 (en) | 1990-09-20 |
| EP0527720A1 (en) | 1993-02-24 |
| IE900818L (en) | 1990-09-15 |
| CA2049980A1 (en) | 1990-09-16 |
| ZA901945B (en) | 1991-01-30 |
| AU640128B2 (en) | 1993-08-19 |
| JPH04503806A (ja) | 1992-07-09 |
| DK0527720T3 (da) | 1994-12-05 |
| DE69011692D1 (de) | 1994-09-22 |
| IE65902B1 (en) | 1995-11-29 |
| ES2057542T3 (es) | 1994-10-16 |
| AU5261690A (en) | 1990-10-09 |
| IL93744A0 (en) | 1990-12-23 |
| EP0527720B1 (en) | 1994-08-17 |
| ATE109981T1 (de) | 1994-09-15 |
| DE69011692T2 (de) | 1994-12-01 |
| KR920700642A (ko) | 1992-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070009614A1 (en) | Composition and method for treating hypertension | |
| BG65474B1 (bg) | Използване на рамиприл за профилактика на кардиоваскуларни смущения | |
| Jounela et al. | Relation between low dose of hydrochlorothiazide, antihypertensive effect and adverse effects | |
| CA2013801A1 (en) | Synergistic compositions containing ketanserin | |
| EP2837380B1 (en) | Lercanidipine hydrochloride and losartan potassium compound preparation and preparation method thereof | |
| WO2010097501A2 (en) | A combination treatment | |
| RU2182002C2 (ru) | Композиция с фиксированной дозой ингибитора ангиотензин-превращающего фермента и антагониста кальциевых каналов, способ ее изготовления и применение для лечения сердечно-сосудистых заболеваний | |
| JP2002535367A5 (es) | ||
| AU640128B2 (en) | Therapeutic agents | |
| JP2005516050A (ja) | 急性心筋梗塞のための複合治療 | |
| AU2003201980A1 (en) | A combination treatment for acute myocardial infarction | |
| AU5695600A (en) | Use of cortisol antagonists in the treatment for heat failure | |
| US20100249103A1 (en) | combination treatment | |
| CA2511735C (en) | A method for treating renal failure using levosimendan or its metabolite or salts thereof | |
| Gavras et al. | Clinical utility of angiotensin converting enzyme inhibitors in hypertension | |
| US20040180895A1 (en) | Use of a pyridazinone derivative | |
| WO2011027021A1 (en) | A method for the treatment of hypertension | |
| CA2412213C (en) | A method for treating septic shock | |
| Carlsen et al. | Comparison of efficacy and tolerability of spirapril and nitrendipine in arterial hypertension | |
| Madias | The long‐term outcome of patients who suffered and survived an acute myocardial infarction in the midst of recurrent attacks of variant angina | |
| Karpati et al. | Long-term tolerability and efficacy of the fixed combination of manidipine and delapril in patients with essential hypertension | |
| JPH0296564A (ja) | 薬剤組成物及び（ｓ，ｓ）‐ｎ‐（３‐（４‐メトキシベンゾイルチオ）‐２‐メチル‐プロピオニル）‐プロリン | |
| US20070099850A1 (en) | Combination of acetylsalicylic acid and alpha-glucosidase inhibitors | |
| KANTILAL | COMPARISON OF FOSINOPRIL, AND PROPRANOLOL, COMBINED WITH CHLORTHALIDONE IN THE TREATMENT OF MODERATELY TO SEVERELY HYPERTENSIVE BLACK AND | |
| KR20180132911A (ko) | 베타 차단제, 전환 효소 억제제 및 항고혈압제 또는 nsaid를 포함하는 약학적 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| RH | Patent void |